John R Moore

Companies

E Edgewise Therapeutics, Inc.General Counsel −$0.2M

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.